Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Exponent (EXPO) EBT (2016 - 2026)

Exponent filings provide 17 years of EBT readings, the most recent being -$103.0 million for Q1 2026.

  • On a quarterly basis, EBT changed 0.07% to -$103.0 million in Q1 2026 year-over-year; TTM through Jan 2026 was $10.2 million, a 22.23% decrease, with the full-year FY2026 number at $10.2 million, down 22.23% from a year prior.
  • EBT hit -$103.0 million in Q1 2026 for Exponent, down from $38.6 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $40.4 million in Q1 2024 to a low of -$103.0 million in Q1 2026.
  • Median EBT over the past 5 years was $35.5 million (2022), compared with a mean of $18.2 million.
  • Biggest five-year swings in EBT: grew 13.75% in 2024 and later crashed 442.02% in 2025.
  • Exponent's EBT stood at $30.5 million in 2022, then dropped by 1.41% to $30.1 million in 2023, then rose by 19.44% to $35.9 million in 2024, then grew by 7.46% to $38.6 million in 2025, then tumbled by 366.66% to -$103.0 million in 2026.
  • The last three reported values for EBT were -$103.0 million (Q1 2026), $38.6 million (Q4 2025), and $36.8 million (Q3 2025) per Business Quant data.